Corcept Therapeutics Inc
CORT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $1.72M | — | — |
| Net Income | -$12.08M | -$11.03M | -$7.10M |
| EPS Diluted | -$0.12 | -$0.13 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR